Rapibloc
Recall
|
Medicines
|
13/11/2018
The marketing authorization holder has informed its supplied customers by letter dated Nov. 12, 2018, that due to a slightly increased exceedance of the specification for known impurities, the above batch is being recalled.
| Name of the medicinal product | Rapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung |
|---|---|
| Marketing authorisation number(s) | 137586 |
| Marketing authorisation holder | Amomed Pharma GmbH |
| Batch number(s) | 8B631A |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-2 691 |
Further inquiry note
Page last modified:
12/07/2022